164 related articles for article (PubMed ID: 25791813)
1. G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin.
Qi R; Zhang H; Xu L; Shen W; Chen C; Wang C; Cao Y; Wang Y; van Dongen MA; He B; Wang S; Liu G; Banaszak Holl MM; Zhang Q
Nanomedicine; 2015 Jul; 11(5):1141-51. PubMed ID: 25791813
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia.
Kulhari H; Kulhari DP; Prajapati SK; Chauhan AS
Mol Pharm; 2013 Jul; 10(7):2528-33. PubMed ID: 23692066
[TBL] [Abstract][Full Text] [Related]
3. Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes.
Ma Q; Han Y; Chen C; Cao Y; Wang S; Shen W; Zhang H; Li Y; van Dongen MA; He B; Yu M; Xu L; Banaszak Holl MM; Liu G; Zhang Q; Qi R
Mol Pharm; 2015 Mar; 12(3):665-74. PubMed ID: 25587935
[TBL] [Abstract][Full Text] [Related]
4. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
5. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics.
Ahmed OA; Hosny KM; Al-Sawahli MM; Fahmy UA
Drug Des Devel Ther; 2015; 9():655-62. PubMed ID: 25670883
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
Kulhari H; Pooja D; Prajapati SK; Chauhan AS
Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
[TBL] [Abstract][Full Text] [Related]
7. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
8. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
9. Optimized microemulsions and solid microemulsion systems of simvastatin: characterization and in vivo evaluation.
Dixit RP; Nagarsenker MS
J Pharm Sci; 2010 Dec; 99(12):4892-902. PubMed ID: 20648662
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic and calorimetric studies of formation of the supramolecular complexes of PAMAM G5-NHâ‚‚ and G5-OH dendrimers with 5-fluorouracil in aqueous solution.
Buczkowski A; Olesinski T; Zbicinska E; Urbaniak P; Palecz B
Int J Pharm; 2015 Jul; 490(1-2):102-11. PubMed ID: 25997661
[TBL] [Abstract][Full Text] [Related]
11. Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.
Sadekar S; Ghandehari H
Adv Drug Deliv Rev; 2012 May; 64(6):571-88. PubMed ID: 21983078
[TBL] [Abstract][Full Text] [Related]
12. Study of the interactions of PAMAM G3-NH2 and G3-OH dendrimers with 5-fluorouracil in aqueous solutions.
Buczkowski A; Waliszewski D; Urbaniak P; Palecz B
Int J Pharm; 2016 May; 505(1-2):1-13. PubMed ID: 27039147
[TBL] [Abstract][Full Text] [Related]
13. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport.
Hong S; Bielinska AU; Mecke A; Keszler B; Beals JL; Shi X; Balogh L; Orr BG; Baker JR; Banaszak Holl MM
Bioconjug Chem; 2004; 15(4):774-82. PubMed ID: 15264864
[TBL] [Abstract][Full Text] [Related]
14. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
[TBL] [Abstract][Full Text] [Related]
15. Efficient lung-targeted delivery of risedronate sodium/vitamin D3 conjugated PAMAM-G5 dendrimers for managing osteoporosis: Pharmacodynamics, molecular pathways and metabolomics considerations.
Elsayyad NME; Gomaa I; Salem MA; Amer R; El-Laithy HM
Life Sci; 2022 Nov; 309():121001. PubMed ID: 36174709
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
[TBL] [Abstract][Full Text] [Related]
17. Characterization, Optimization, In Vitro and In Vivo Evaluation of Simvastatin Proliposomes, as a Drug Delivery.
Rahamathulla M; H V G; Veerapu G; Hani U; Alhamhoom Y; Alqahtani A; Moin A
AAPS PharmSciTech; 2020 May; 21(4):129. PubMed ID: 32405982
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system.
Ke W; Zhao Y; Huang R; Jiang C; Pei Y
J Pharm Sci; 2008 Jun; 97(6):2208-16. PubMed ID: 17879294
[TBL] [Abstract][Full Text] [Related]
19. Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue.
Hubbard D; Enda M; Bond T; Moghaddam SP; Conarton J; Scaife C; Volckmann E; Ghandehari H
Mol Pharm; 2015 Nov; 12(11):4099-107. PubMed ID: 26414679
[TBL] [Abstract][Full Text] [Related]
20. Solubility enhancement of simvastatin: a review.
Murtaza G
Acta Pol Pharm; 2012; 69(4):581-90. PubMed ID: 22876598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
